PMCB Stock Analysis: Buy, Sell, or Hold?
PMCB - PharmaCyte Biotech, Inc. Common Stock
$0.79
0.07 (9.64%)
▲
5d:
+3.42%
30d:
+2.45%
90d:
+14.59%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Mar 16, 2026
0d
Get Alerted When PMCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PMCB shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PMCB shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PMCB is currently trading at $0.79, which is considered fair relative to its 30-day fair value range of $0.72 to $0.83.
Technical Outlook: Technically, PMCB is showing sideways momentum. Immediate support is located at $0.67, while resistance sits at $0.87. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: PMCB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PMCB is showing sideways momentum. Immediate support is located at $0.67, while resistance sits at $0.87. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: PMCB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.72 -
$0.83
Company Quality Score
58/100
(HOLD)
Options IV Signal
58th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
86.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 58th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.6%)
Trading Range Analysis
30-Day Trading Range
$0.72 -
$0.83
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.38
(48.9%)
Support & Resistance Levels
Support Level
$0.67
Resistance Level
$0.87
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.02
Share & Embed Analysis
Last updated: June 22, 2026 2:03 PM ET
Data refreshes hourly during market hours. Next update: 3:03 PM
Data refreshes hourly during market hours. Next update: 3:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMCB showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jonathan Schechter
BUY
20000 shares
2026-01-07
Joshua Silverman
BUY
40000 shares
2026-01-07
Jonathan Schechter
BUY
20000 shares
2026-01-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 67 BUY |
